1. Yamamoto N, Eguchi A, Hirokawa Y, Ogura S, Sugimoto K, Iwase M, Watanabe M, Takei Y. Expression pattern of PLXDC2 in human hepatocellular carcinoma. Monoclon Antib Immunodiagn Immunother. 39(2), 57-60, 2020.

2. Mahmud MRA, Ishii K, Bernal-Lozano C, Delgado-Sainz I, Toi M, Akamatsu S, Fukumoto M, Watanabe M, Takeda S, Cortes-Ledesma F, Sasanuma H. TDP2 suppresses genomic instability induced by androgens in the epithelial cells of prostate glands. Genes to Cells, 00, 1-16, 2020.

3. Sonoda Y, Sasaki Y, Gunji A, Shirai H, Araki T, Imamichi S, Onodera T, Rydén A-M, Watanabe M, Itami J, Honda T, Ashizawa K, Nakao K, Masutani M.  Reduced tumorigenicity of mouse ES cells and the augmented anti-tumor therapeutic effects under Parg deficiency. Cancers, 12(4), 1056, 2020.

4. Mizutani K, Shirakami E, Ichishi M, Matsushima Y, Umaoka A, Okada K, Yamaguchi Y, Watanabe M, Morita E, Yamanaka K. Long-lasting severe dermatitis affect visceral adipose tissue via skin-derived inflammatory cytokines. Int J Med Sci, 21, 3367, 2020.

5. Kanayama K, Imai H, Usugi E, Matsuda C, Ichishi M, Hirokawa YS, Watanabe M. Cancer-related gene mutations and intratumoral genetic heterogeneity in human epidermal growth factor receptor 2 heterogeneous gastric cancer
Pathol Int, in press, 2020.

6. Amemiya T, Shibata K, Watanabe M, Nakata S, Nakamura K, Yamaguchi T. "Glycolytic oscillations in cancer cells", McClntock P. and Stefanovska A. Eds. in Physics of Biological Oscillations, Springer, in press

7. Totsuka Y, Watanabe M, Lin Y. New horizons of DNA adductor for exploring environmental causes of cancer. Cancer Sci, accepted

8. Hirokawa Y, Kanayama K, Kagaya M, Shimojo N, Uchida K, Imai H, Ishii K, Watanabe M. SOX11-induced decrease in vimentin and an increase in prostate cancer cell migration attributed to cofilin activity. Exp Mol Pathol. 117:104542. 2020.

9. Sawada Y, Nakai Y, Yokota N, Habe K, Hayashi A, Yamanaka K. Voriconazole-Induced Squamous Cell Carcinoma after Hematopoietic Stem Cell Transplantation Showing Early-Stage Vascular Invasion. Dermatopathology (Basel). 7(3):48-52. 2020.


1. Ishii K, Sasaki T, Iguchi K, Kato M, Kanda H, Hirokawa Y, Arima K, Watanabe M, Sugimura Y. Pirfenidone, an anti-fibrotic drug, suppresses the growth of human prostate cancer cells by inducing G1 cell cycle arrest. J Clin Med, 8(1), 44, 2019.

2. Sasaki T, Franco OE, Ohishi K, Ishii K, Crawford SE, Takahashi N, Katayama N, Sugimura Y, Hayward SW. Tyrosine kinase inhibitor therapy prescribed for non-urologic diseases can modify PSA titers in urology patients. Prostate. 79(3), 259-264, 2019.

3. Usugi E, Ishii K, Hirokawa Y, Kanayama K, Matsuda C, Uchida K, Shiraishi T, Watanabe M. Anti-fibrotic agent pirfenidone suppresses proliferation of human pancreatic cancer cells by inducing G0/G1 cell cycle arrest. Pharmacology. 103(5-6), 250-256. 2019.

4. Kanayama K, Imai H, Usugi E, Shiraishi T, Hirokawa YS, Watanabe M. Letter to editor: reply to Antonio Ieni "Intratumoral HER2 heterogeneity in early gastric carcinomas: potential bias in therapeutical management". Virchows Arch. 474(3), 403-404, 2019.

5. Ishii K, Matsuoka I, Sasaki T, Nishikawa K, Kanda H, Imai H, Hirokawa Y, Iguchi K, Arima K, Sugimura Y. Loss of fibroblast-dependent androgen receptor activation in prostate cancer cells is involved in the mechanism of acquired resistance to castration. J Clin Med. 8(9), E1379, 2019. 

6. 石井健一朗, 前立腺がん治療反応性に関わる線維芽細胞の多様性, 医学のあゆみ, 270 (12), 1125-1131, 2019.

7. Kajiwara S, Ishii K, Sasaki T, Kato M, Nishikawa K, Kanda H, Arima K, Watanabe M, Sugimura Y. Castration-induced stromal remodeling disrupts the reconstituted prostate epithelial structure. Laboratory Investigation (in press)

8. Ishii K. Cytobiology of human prostate cancer cells and its clinical applications. J Clin Med. 8(10), E1716, 2019.

9. Endo M, Katayama K, Matsuo H, Horiike S, Nomura S, Hayashi A, Ishikawa E, Harada T, Sugimoto R, Tanemura A, Sugimoto K, Isaji S, Ito M. Role of Liver Transplantation in Tolvaptan-Associated Acute Liver Failure. Kidney Int Rep. 4(11):1653-1657. 2019.

10. Nakamura A, Tawara I, Ino K, Matsumoto T, Hayashi A, Imai H, Muraosa Y, Kamei K, Katayama N. Achievement of long-term remission of disseminated histoplasmosis in an AIDS patient. Med Mycol Case Rep. 27:25-28. 2019.

11. Matsushima Y, Hayashi A, Mizutani K, Kondo M, Nakai Y, Habe K, Yamaguchi Y, Kozuka Y, Wakabayashi H, Yamanaka K. Psoriasiform Dermatitis Developing during Treatment of Juvenile Idiopathic Arthritis with Tocilizumab. Case Rep Dermatol. 11:317–321, 2019.

Tanaka F, Matsukawa M, Kogue R, Umino M, Maeda M, Uchida KImai H, Matsubara T, Sakuma H. A case of a rosette-forming glioneuronal tumor arising from the pons withdisappearance of contrast enhancement. Radiol Case Rep. 14(8):899-902. 2019.

Hayasaki A, Murata Y, Usui M, Hibi T, Fujii T, Iizawa Y, Kato H, Tanemura A, Azumi Y, Kuriyama N, Kishiwada M, Mizuno S, Sakurai H, Uchida K, Isaji S. Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes. Biomed Res Int. doi: 10.1155/2019/5738614. 2019.

14. Hattori T, Matsumine A, Uchida K, Nojima T, Sudo A. Benign Fibrous Histiocytoma of the Talus: A Case Report. J Foot Ankle Surg. 58(4):762-765. 2019.


1. Kanayama K, Imai H, Usugi E, Shiraishi T, Hirokawa YS, Watanabe M. Association of HER2 gene amplification and tumor progression in early gastric cancer. Virchows Arch. 473(5):559-565, 2018.

2. Kojima K, Takahashi S, Saito S, Endo Y, Nittami T, Nozaki T, Sobti RC, Watanabe M. Combined effects of Fe3O4 nanoparticles and chemotherapeutic agents on prostate cancer cells in vitro. Applied Sciences, 8(1), 134, 2018.

3. Fukai E, Sato H, Watanabe M, Nakae D, Tostuka Y. Establishment of an in vivo simulating co-culture assay platform for genotoxicity of multi-walled carbon nanotubes. Cancer Sci, 109(4), 1024-1031, 2018.

4. Ishii K, Takahashi S, Sugimura Y, Watanabe M. Role of stromal paracrine signals in proliferative diseases of the aging human prostate. J. Clin. Med., 7(4), 68, 2018.

5. Lee GW, Park JB, Park SY, Seo J, Shin SH, Park JW, Kim SJ, Watanabe M, Chun YS.  The E3 ligase C-CBL inhibits cancer cell migration by neddylating the proto-oncogene c-Src.  Oncogene, 37(41), 5552-5568, 2018.

6. Fujiwara Y, Nishida M, Saito M, Robles AI, Takeshita F, Watanabe M, Ochiya T, Yokota J, Kohno T, Harris CC, Tsuchiya N. A nucleolar stress–specific p53–miR-101 molecular circuit functions as an intrinsic tumor-suppressor network. EBioMedicine, 33, 33-48, 2018.

7. Kudo Y, Sasaki Y, Onodera T, Hashimoto J, Nozaki T, Tamura K, Watanabe M, Masutani M. Measurement of poly(ADP-ribose) level with enhanced slot blot assay with crosslinking. Challenges 9(2), 27, 2018

8. Hayashi K, Yamada S, Sakamoto W, Usugi E, Watanabe M, Yogo T. Red Blood Cell-Shaped Microparticles with Red Blood Cell Membrane Demonstrate Prolonged Circulation Time in Blood. ACS Biomaterials Sci. Eng. 4(8), 2729-2732, 2018.

9. Miki M, Ishii K, Sasaki T, Kato M, Kajiwara S, Kanda H, Arima K, Hirokawa Y, Watanabe M, Sugimura Y. Predicting the tumorigenic phenotype of human bladder cancer cells by combining with fetal rat mesenchyme. Urol. Oncol. 36(10), 472.e1-472.e9, 2018.

10. Ishii K, Sasaki T, Iguchi K, Kajiwara S, Kato M, Kanda H, Hirokawa Y, Arima K, Mizokami A, Sugimura Y. Interleukin-6 induces VEGF secretion from prostate cancer cells in a manner independent of androgen receptor activation. Prostate, 78: 849-856, 2018. 

11. Ishii K, Matsuoka I, Kajiwara S, Sasaki T, Miki M, Kato M, Kanda H, Arima K, Shiraishi T, Sugimura Y. Additive naftopidil treatment synergizes docetaxel-induced apoptosis in human prostate cancer cells. J Cancer Res Clin Oncol, 144(1) 89-98, 2018.

12. Nakaguro M, Urano M, Suzuki H, Yamada K, Sakaguchi A, Ogura K, Matsumoto T, Ono N, Asato T, Mikami Y, Imai H, Nagao T. Low-grade intraductal carcinoma of the salivary gland with prominent oncocytic change: a newly described variant. Histopathology, 73(2), 314-320. 2018. 

13. Imai N, Kitayama M, Shibahara A, Bessho Y, Shibusawa M, Noro A, Inakami K, Hanamura N, Imai H, Ogawa T. Strategy for the accurate preoperative evaluation of the number of metastatic axillary lymph nodes in breast cancer. Asian J Surg. 2018 Apr 13. pii: S1015-9584(17)30571-7. doi: 10.1016/j.asjsur.2018.03.003.

14. Mizoguchi S, Katayama K, Murata T, Ishikawa E, Kozuka Y, Honda Y, Oda K, Hirabayashi Y, Ito T, Ito M. IgM-Positive Tubulointerstitial Nephritis Associated With Asymptomatic Primary Biliary Cirrhosis. Kidney Int Rep. 3(4), 1004-1009, 2018. 

15. Ueno N, Kuroda H, Kurosumi M, Kozuka Y, Ito J, Kato H, Kubota K, Imai Y. Clinicopathological study of a dimorphic variant of breast carcinoma. Breast Cancer. 25(2):151-158, 2018.

16. 内田克典, 現代のグリソン分類とISUPグレードグループ分類. 腎臓内科・泌尿器科. 7, 256-62, 2018.

17. 湯淺博登, 萩原仁美, 藤田祐一, 臼井美希, 馬場洋一郎, 村田哲也, 渡邉昌俊. 鼻腔に生じた鼻硬化腫の1診断病理35(3), 206-9, 2018.

18. 石井健一朗, 佐々木豪, 渡邉昌俊, 杉村芳樹. リガンド非依存的なアンドロゲン受容体活性化機構の多様性から考える前立腺癌治療の課題と展望. 泌尿器外科, 31 (8), 1123-1125, 2018.

19. 小塚祐司, 湯淺博登, 渡邉昌俊. 結合織性および上皮混合性腫瘍, 非上皮性腫瘍, その他病変. 病理と臨床, 36(9), 894-902, 2018.

20. Nishimura Y, Kasahara K, Shiromizu T, Watanabe M, Inagaki M. Primary cilia as signaling hubs in health and disease. Adv. Sci. 1801138, 2018

21. Kurihara K, Toyoda H, Amoano K, Inoue M, Uchida K, Sakurai H, Hayashi A, Hirayama M. Discontinuation of NTBC after liver transplantation in tyrosinemia type 1. Pediatr Int. 60(11), 1039-1041, 2018

22. Murata Y, Ando K, Usui M, Sugiyama H, Hayashi A, Tanemura A, Kuriyama N, Kishiwada M, Mizuno S, Sakurai H, Isaji S. A case of hepatic anisakiasis caused by Pseudoterranova decipiens mimicking metastatic liver cancer. BMC Infect Dis. 18:619, 2018

23. Onishi T, Sekito S, Shibahara T, Uchida K, Sasaki T. The role of continuous saline bladder irrigation after transurethral resection in patients with high-grade non-muscle-invasive bladder cancer. Scand J Urol. 52(5-6):385-388. 2018.


1. Amemiya T, Shibata K, Itoh Y, Itoh K, Watanabe M, Yamaguchi T. Primordial oscillations in life: Direct observantion of glycolytic oscillations in individual HeLa cervical cancer cells. Chaos. 2017 Oct; 27(10): 104602.

2. Kato T, Toyooka T, Ibuki Y, Masuda S, Watanabe M, Totsuka Y. Effects of physicochemical character differences on the genotoxic potency of kaolin. Genes Environ. 2017 May 1;39:12.

3. Shimojo N, Hirokawa YS, Kanayama K, Yoneda M, Hashizume R, Hayashi A, Uchida K, Imai H, Kozuka Y, Shiraishi T. Cytological features of adenocarcinoma admixed with small cell neuroendocrine carcinoma of the uterine cervix. Cytojournal. 2017 May 26;14:12.

4. Iwamoto Y, Ishii K, Kanda H, Kato M, Miki M, Kajiwara S, Arima K, Shiraishi T, Sugimura Y. Combination treatment with naftopidil increases the efficacy of radiotherapy in PC-3 human prostate cancer cells. J Cancer Res Clin Oncol, 143(6), 933-939, 2017.

5. Takeuchi T, Yamaguchi M, Kobayashi K, Miyazaki K, Tawara I, Imai H, Ono R, Nosaka T, Tanaka K, Katayama N. MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma. 23(7), 1166-1173, Cancer. 2017.

6. Kawasaki T, Saito T, Uchida K, Mio K, Nishida H, Homma K. A case of mucin-producing urothelial-type adenocarcinoma of the prostate showing immunoreactivity for NKX3.1, a specific marker of prostatic tissue. Pathol Int, 67(9), 483-484, 2017

7. Sakaida H, Yuasa H, Fukutome K, Takeuchi K. Pharyngolaryngeal ulcers associated with the improper use of alendronate.  Auris Nasus Larynx. 44(6), 762-5, 2017.

8. 内田克典, 森尾邦正, 栗山直久, 臼井正信, 伊佐地秀司. 胆道癌に対する術前治療後の病理組織学的効果判定法. 胆と膵. 38(5), 433-7, 2017.

9. 松島由明, 波部幸司, 山中恵一, 水谷仁, 今井裕, 渡邉昌俊. Primary cutaneous myxoid spindle cell squamous cell carcinoma. 皮膚病診療. 9, 949-52, 2017.

10. 石井健一朗, 杉村 芳樹. 前立腺肥大結節の発生・進展における上皮-間質相互作用, Prostate Journal, 4 (1): 105-114, 2017.